University of Kiel

Sulthiame Shows Promise in Treating Obstructive Sleep Apnea, Leads ERS Congress 2024 Highlights

6 months ago

• A clinical trial presented at ERS Congress 2024 revealed that sulthiame, an epilepsy medication, effectively reduced obstructive sleep apnea symptoms by improving oxygen levels and decreasing breathing interruptions during sleep. • Researchers at ERS Congress discussed critical findings on lung function decline in IPF and PPF patients, demonstrating that even minor decreases in lung function significantly impact mortality risk and transplant likelihood. • The congress highlighted emerging trends in respiratory medicine, including AI-powered robotics potential in clinical care and key lessons from failed IPF trials emphasizing the need for improved trial design.